Joinn Laboratories(China)Co.Ltd (6127) Stock Overview
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
6127 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
100% Patient Improvement in trial puts this $16M Biotech on the radar
Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.62 |
| 52 Week High | CN¥28.70 |
| 52 Week Low | CN¥7.88 |
| Beta | 0.87 |
| 1 Month Change | 8.13% |
| 3 Month Change | 25.53% |
| 1 Year Change | 101.60% |
| 3 Year Change | 9.20% |
| 5 Year Change | n/a |
| Change since IPO | -56.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6127 | HK Life Sciences | HK Market | |
|---|---|---|---|
| 7D | -2.1% | 11.5% | 2.9% |
| 1Y | 101.6% | 87.1% | 20.7% |
Return vs Industry: 6127 exceeded the Hong Kong Life Sciences industry which returned 87.1% over the past year.
Return vs Market: 6127 exceeded the Hong Kong Market which returned 20.7% over the past year.
Price Volatility
| 6127 volatility | |
|---|---|
| 6127 Average Weekly Movement | 11.4% |
| Life Sciences Industry Average Movement | 8.2% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in HK Market | 15.8% |
| 10% least volatile stocks in HK Market | 3.4% |
Stable Share Price: 6127's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6127's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,551 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 6127 fundamental statistics | |
|---|---|
| Market cap | HK$26.60b |
| Earnings (TTM) | HK$333.05m |
| Revenue (TTM) | HK$2.01b |
Is 6127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6127 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.84b |
| Cost of Revenue | CN¥1.42b |
| Gross Profit | CN¥413.19m |
| Other Expenses | CN¥108.44m |
| Earnings | CN¥304.75m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 31, 2025
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 22.49% |
| Net Profit Margin | 16.58% |
| Debt/Equity Ratio | 0% |
How did 6127 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/04 03:29 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Joinn Laboratories(China)Co.,Ltd. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Jin Zhang | China International Capital Corporation Limited |
| Yong Jian Li | China Merchants Securities Co. Ltd. |